Full-Time

Quality Control Manager

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

Compensation Overview

$100k - $120k/yr

Chantilly, VA, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Biochemistry

Get referred to Granules

See people who can refer or advise you

Requirements
  • A minimum Bachelor of Arts or Bachelor of Science degree in Biochemistry, Chemistry, or a related field.
  • Ten to fifteen years of experience in the biotechnology or pharmaceutical industry.
  • Management experience in Quality Control is required.
  • Ability to maintain integrity and honesty at all times.
  • Ability to communicate and lead with transparency.
  • Accountability for department performance and results.
  • Ability to assume additional responsibilities on one's own initiative.
  • Ability to stand for four to six hours per day while performing chemical tests.
  • Ability to work regularly in a laboratory environment while wearing lab coats and safety glasses.
Responsibilities
  • Supervise testing of bulk release, finished products, and stability samples.
  • Manage and supervise QC laboratory personnel with varying levels of experience, assign work schedules, and ensure assigned tasks are performed.
  • Review test results for accuracy and proper documentation.
  • Review specifications and standard test methods for in-process and finished products.
  • Write out-of-specification investigations, including determining root causes and corrective and preventive actions.
  • Supervise laboratory processes, including timely investigation management and CAPA implementation to ensure sustainable compliance.
  • Review standard operating procedures, laboratory-related investigations, stability failure notifications, certificates of analysis, and compiled stability data.
  • Ensure timely release of in-process and finished-product certificates of analysis.
  • Monitor and report trends in bulk, finished-product, and stability samples to QC/QA management.
  • Review installation qualification, operational qualification, and performance qualification documentation for new instruments, including protocols and reports.
  • Coordinate with warehouse, quality assurance, maintenance, purchasing, and research and development departments on daily operational requirements and current good manufacturing practice compliance.
  • Coordinate sample management for in-process, finished-product, and stability samples.
  • Monitor Quality Control, safety, and current good manufacturing practice practices to ensure compliance with internal and external regulations.
  • Manage a group of scientists.
  • Perform other related duties as assigned to meet departmental and company objectives.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours